adBlockCheck

Wonder Drug Inspires Deep, Unwavering Love Of Pharmaceutical Companies

Top Headlines

Science & Technology

NASA Discovers Distant Planet Located Outside Funding Capabilities

WASHINGTON—Noting that the celestial body lies within the habitable zone of its parent star and could potentially harbor liquid water, NASA officials announced at a press conference Thursday they have discovered an Earth-like planet located outside their funding capabilities.

‘DSM-5’ Updated To Accommodate Man Who Is Legitimately Being Ordered To Kill By The Moon

ARLINGTON, VA—Saying they were committed to ensuring the influential reference text accurately represented all known psychological conditions, leading members of the American Psychiatric Association announced Monday they would update the Diagnostic And Statistical Manual Of Mental Disorders, Fifth Edition to accommodate a man who is legitimately being ordered by the moon to kill those around him.

NASA Launches First Cordless Satellite

CAPE CANAVERAL, FL—In what experts are calling a breakthrough achievement that is poised to revolutionize American space exploration and telecommunications, NASA announced Friday it has successfully launched its first cordless satellite into orbit.

What Is Pokémon Go?

Since its debut last Thursday, the augmented-reality smartphone app Pokémon Go has been downloaded millions of times and has grown publisher Nintendo’s stock by 25 percent. The Onion answers some common questions about the game and its unprecedented success.

Factory Robot Working On Some Of Its Own Designs After Hours

NORTH CHARLESTON, SC—Saying it had been mulling over the “fun little side project” for a while, an Electroimpact Quadbot reportedly put in some extra work after hours at the Boeing assembly plant Wednesday to try out a few of its own original designs.

Books Vs. E-Readers

Though e-readers have increasingly supplanted books in the digital age, many bibliophiles defend the importance of physical texts. Here is a side-by-side comparison of physical books and e-books

Disney Begins Uploading Obama’s Consciousness To Hall Of Presidents Robot

BAY LAKE, FL—In an effort to provide park visitors with the most true-to-life attraction possible, Walt Disney World officials announced Monday that computer technicians have begun uploading Barack Obama’s consciousness into his animatronic robot likeness at the Magic Kingdom’s Hall of Presidents exhibit.

Facebook’s Plans For The Future

From instant articles to live video, Facebook continues to look for new ways to expand its reach and offerings. Here are some plans on the horizon for the social media giant

Brita Unveils New In-Throat Water Filters

OAKLAND, CA—Representatives from Brita, the nation’s bestselling brand of household water filtration products, held a press event Wednesday to unveil a new line of filters designed to be installed directly inside users’ throats.

Video Game Henchmen Plan Meetup Around Explosive Barrels

LEVEL 5—A group of video game henchmen patrolling the warehouse hideout of their criminal mastermind boss informed reporters Wednesday of their upcoming plan to take a brief break from making their rounds to meet up around a stack of five highly explosive barrels.

Study Links Clinical Depression To Getting Dunked On

BOSTON—Identifying a significant factor contributing to the development of the mental health disorder, researchers from Harvard Medical School published a groundbreaking study Thursday that reportedly links clinical depression to getting dunked on.
End Of Section
  • More News
Up Next

Wonder Drug Inspires Deep, Unwavering Love Of Pharmaceutical Companies

NEW YORK—The Food and Drug Administration today approved the sale of the drug PharmAmorin, a prescription tablet developed by Pfizer to treat chronic distrust of large prescription-drug manufacturers.

Pfizer executives characterized the FDA's approval as a "godsend" for sufferers of independent-thinking-related mental-health disorders.

PharmAmorin, now relieving distrust of large pharmaceutical conglomerates in pharmacies nationwide.

"Many individuals today lack the deep, abiding affection for drug makers that is found in healthy people, such as myself," Pfizer CEO Hank McKinnell said. "These tragic disorders are reaching epidemic levels, and as a company dedicated to promoting the health, well-being, and long life of our company's public image, it was imperative that we did something to combat them."

Although many psychotropic drugs impart a generalized feeling of well-being, PharmAmorin is the first to induce and focus intense feelings of affection externally, toward for-profit drug makers. Pfizer representatives say that, if taken regularly, PharmAmorin can increase affection for and trust in its developers by as much as 96.5 percent.

"Out of a test group of 180, 172 study participants reported a dramatic rise in their passion for pharmaceutical companies," said Pfizer director of clinical research Suzanne Frost. "And 167 asked their doctors about a variety of prescription medications they had seen on TV."

Frost said a small percentage of test subjects showed an interest in becoming lobbyists for one of the top five pharmaceutical companies, and several browsed eBay for drug-company apparel.

PharmAmorin, available in 100-, 200-, and 400-mg tablets, is classified as a critical-thinking inhibitor, a family of drugs that holds great promise for the estimated 20 million Americans who suffer from Free-Thinking Disorder.

Pfizer will also promote PharmAmorin in an aggressive, $34.6 million print and televised ad campaign.

One TV ad, set to debut during next Sunday's 60 Minutes telecast, shows a woman relaxing in her living room and reading a newspaper headlined "Newest Drug Company Scandal Undermines Public Trust." The camera zooms into the tangled neural matter of her brain, revealing a sticky black substance and a purplish gas.

The narrator says, "She may show no symptoms, but in her brain, irrational fear and dislike of global pharmaceutical manufacturers is overwhelming her very peace of mind."

After a brief summary of PharmAmorin's benefits, the commercial concludes with the woman flying a kite across a sunny green meadow, the Pfizer headquarters gleaming in the background.

PharmAmorin is the first drug of its kind, but Pfizer will soon face competition from rival pharmaceutical giant Bristol-Myers Squibb. The company is developing its own pro-pharmaceutical-company medication, Brismysquibicin, which will induce warm feelings not just for drug corporations in general, but solely for Bristol-Myers Squibb.

"A PharmAmorin user could find himself gravitating toward the products of a GlaxoSmithKline or Eli Lilly," BMS spokesman Andrew Fike said. "This could seriously impede the patient's prescription-drug-market acceptance, or worse, Pfizer's profits in the long run."

"Brismysquibicin will be cheaper to produce and therefore far more affordable to those on fixed incomes," Fike added.

The news of an affordable skepticism-inhibitor was welcomed by New York physician Christine Blake-Mann, who runs a free clinic in Spanish Harlem.

"A lot of my patients are very leery of the medical establishment," Blake-Mann said. "This will help them feel better about it, and save money at the same time."

PharmAmorin's side effects include nausea, upset stomach, and ignoring the side effects of prescription drug medication.

Sign up For The Onion's Newsletter

Give your spam filter something to do.

X Close